Espeland, Mark A <br/><br/>
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.  [electronic resource] 

 -  Diabetes care  Dec 2015 
 - 2316-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc15-1385  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Brain--drug effects<br/>Cognition--drug effects<br/>Cognition Disorders--chemically induced<br/>Dementia--chemically induced<br/>Diabetes Mellitus, Type 2--blood<br/>Estrogen Replacement Therapy--adverse effects<br/>Estrogens--blood<br/>Estrogens, Conjugated (USP)--adverse effects<br/>Female<br/>Glucose--metabolism<br/>Humans<br/>Incidence<br/>Medroxyprogesterone Acetate--adverse effects<br/>Postmenopause<br/>Randomized Controlled Trials as Topic<br/>Risk